case_images: PMC9709179_01
case_images: Clinical timeline of case report.
case_images: 10.1177_2050313X221137447-fig1.jpg
case_images: PMC9709179_01_10.1177_2050313X221137447-fig1.jpg
case_images: fig1-2050313X221137447
case_images: In May 2020, a 53-year-old Indian male patient presented to our tertiary care hospital clinic with a vague abdominal pain along with significant weight loss (Figure 1).
case_images: CECT images of the patient. (a) Before starting T-DM1. Left adrenal metastasis (yellow arrow) and portocaval lymph node (yellow circle). (b) After three cycles of T-DM1 showing a partial response. (c) Sustained response after six cycles of T-DM1.
case_images: 10.1177_2050313X221137447-fig2.jpg
case_images: PMC9709179_01_10.1177_2050313X221137447-fig2.jpg
case_images: fig2-2050313X221137447
case_images: Thus, he further received second-line chemotherapy with mFOLFIRINOX for four cycles following which he had progressive disease (Figure 2(a)). Imaging done after three cycles showed a partial response (Figure 2(b)). He further received six cycles with a sustained response (Figure 2(c)).